Financial statements Jjp Biologics
Balance sheet of Jjp Biologics
Company age:
Age:
9 y. 6 m. 29 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of JJP BIOLOGICS
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 47 671 151,41 | 84 000 850,76 |
| A. Fixed assets | 51 499,41 | 1 651 527,91 |
| B. Current assets | 47 619 652,00 | 82 349 322,85 |
| C. Share capital contributions (basic funds) | - | 0,00 |
| D. Own shares (stocks) | - | 0,00 |
| Total liabilities | 47 671 151,41 | 84 000 850,76 |
| A. Equity | 39 715 749,32 | 37 952 004,69 |
| B. Liabilities and provisions for liabilities | 7 955 402,09 | 46 048 846,07 |
| I. Long-term liabilities | 0,00 | 34 801 496,35 |
| II. Short-term liabilities | 5 455 402,09 | 4 457 366,49 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.